Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-42.06	102.93	177.66
Graham Fair Price	108.01	2.03	0.98
PEG	-96.30	0.05	-1.41
Price/Book	-10.85	0.98	1.10
Price/Cash Flow	-32.16	4.89	-7.21
Prices/Earnings	-80.61	-28.52	147.12
Price/Sales	34.10	2.70	2.01
Price/FCF	-32.16	4.89	-7.21
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	8.09	0.11	0.10
Operating Margin	-628.32	-0.04	< 0.005
ROA	363.81	< 0.005	< 0.005
ROE	< 0.005	< 0.005	359.87
ROIC	< 0.005	< 0.005	-48.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.12	0.30	-60.54
Dividends QOQ	0.99	1.61	61.49
EBIT QOQ	0.96	-3.70	285.44
EPS QOQ	1.04	-5.47	423.88
FCF QOQ	0.13	2.27	1673.28
Revenue QOQ	0.15	-0.36	136.98
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	455.93	669.38	46.82
Days Sales Outstanding (DSO)	32.82	123.13	275.22
Inventory Turnover	0.20	0.13	-31.89
Debt/Capitalization	0.61	0.58	-4.03
Quick Ratio	0.23	0.32	40.52
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	4.76	6.88	44.63
Cash	3.01	2.83	-6.10
Capex	-0.20	0.11	-43.55
Free Cash Flow	-0.73	0.93	27.47
Revenue	2.61	1.68	-35.51
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.02	0.97	-4.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	85.98	49.33	-42.62
Naive Interpretation	Member

06 - Financial Health · Bad

Rating